Observe Medical ASA
OSE:OBSRV
Observe Medical ASA
Observe Medical ASA engages in the business of developing, marketing, and selling innovative medtech products for the global market. The company is headquartered in Oslo, Oslo. The company went IPO on 2019-11-04. The firm has a broad distribution portfolio of medtech devices and disposables, mainly within Urine measurement, Anesthesiology/ICUs and wound care. The firm is recognized for development and distribution of the Sippi automated digital urine system. Sippi is consist of several products like urine temperature catheters fixating devices to use in combination with urine catheters. Another product Biim is s approved for ultrasound imaging of the human body and is specifically used to guide needle and catheter insertions for dialysis and vascular access procedures. Observe Medical ASA is the parent company of its wholly owned subsidiaries, Observe Medical International AS, Observe Medical AB, Observe Medical ApS, Observe Medical Nordic AB and Biim Ultrasound AS.
Observe Medical ASA engages in the business of developing, marketing, and selling innovative medtech products for the global market. The company is headquartered in Oslo, Oslo. The company went IPO on 2019-11-04. The firm has a broad distribution portfolio of medtech devices and disposables, mainly within Urine measurement, Anesthesiology/ICUs and wound care. The firm is recognized for development and distribution of the Sippi automated digital urine system. Sippi is consist of several products like urine temperature catheters fixating devices to use in combination with urine catheters. Another product Biim is s approved for ultrasound imaging of the human body and is specifically used to guide needle and catheter insertions for dialysis and vascular access procedures. Observe Medical ASA is the parent company of its wholly owned subsidiaries, Observe Medical International AS, Observe Medical AB, Observe Medical ApS, Observe Medical Nordic AB and Biim Ultrasound AS.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
